Abstract:Objective To investigate the effects of celastrol on the growth of human malignant glioma cell line SHG-44 in vivo and study the mechanism that celastrol inhibits the growth of a human malignant glioma cell line SHG-44 in vivo.Methods Animal models were established on BALB/c nude mice with subcutaneously transplanted neoplasma of SHG-44 glioma.The nude mice bearing with SHG44 glioma were devided randomly into five groups, which were treated without drugs or with different doses of celastrol(4mg/kg,2mg/kg and 1mg/kg) or with cisplatin(2mg/kg).The dimension of xenografts was measured and the living state of nude mice with SHG-44 glioma was observed.The protein expression of microvessel density(MVD),bFGF,cyclin D1,PCNA in each paraffin imbedded xenograft of nude mice bearing with SHG-44 glioma were detected by immunohistochemistry staining.Results Celastrol at both 4mg/kg and 2mg/kg inhibited the growth of xenografts in nude mice with SHG44 blioma(P<0.05),and the tumor volume was reduced by 35% and 26.9% in both of celastrol-treated groups respectively compared with that in the dissolvent control.Meanwhile the control group highly expressed bFGF at the level of protein,coupling with increase of MVD.Compared with the dissolvent control group,two groups of celastrol 4mg/kg and 2mg/kg showed lower expression of them(P<0.05) and more decrease in MVD(P<0.05).The protein expression of PCNA and cyclin D1 in two groups of celastrol 4mg/kg and 2mg/kg was dose dependently lower than that in control group(P<0.05).Conclusion Celastrol can inhibit the growth of a human malignant glioma cell line SHG-44 in vivo significantly and dose-dependently.Celastrol can significantly suppress the expression of bFGF, PCNA and cyclin D1 at the level of protein.The mechanism of supressing glioma may be a down-regulation of protein expression of bFGF resucting in the inhibition of angiogenesis.In virtue of regulating cell-cycle,the down-regulation of PCNA and cyclin D1 protein expression may suppress the proliferation of neoplasma.

Celastrol Inhibits the Growth of Human Glioma Xenografts in Nude Mice Through Suppressing VEGFR Expression

Celastrol Inhibits Cancer Metastasis by Suppressing M2-like Polarization of Macrophages.

Celastrol Suppresses Glioma Vasculogenic Mimicry Formation and Angiogenesis by Blocking the PI3K/Akt/mTOR Signaling Pathway

Celastrol inhibits human glioma xenograft

Celastrol on the Inhibition of Human Malignant Glioma Cell Line SHG- 44 in vivo

Effects of celastrol on the SHG44 glioma growth and angiogenesis of nude mouse bearing tumor

Celastrol inhibits the HIF-1α pathway by inhibition of mTOR/p70S6K/eIF4E and ERK1/2 phosphorylation in human hepatoma cells

Celastrol Inhibits the Growth of Ovarian Cancer Cells in Vitro and in Vivo

[Celastrol in the Inhibition of Neovascularization].

Radiosensitizing Effect of Celastrol by Inhibiting G2/M Phase Arrest Induced by the C-Myc Gene of Human SW1353 Chondrosarcoma Cells: Network and Experimental Analyses.

Celastrol induces ubiquitin-dependent degradation of mTOR in breast cancer cells.

Celastrol Acts As a Potent Antimetastatic Agent Targeting Β1 Integrin and Inhibiting Cell-Extracellular Matrix Adhesion, in Part Via the P38 Mitogen-Activated Protein Kinase Pathway

Celastrol suppresses nitric oxide synthases and the angiogenesis pathway in colorectal cancer

Celastrol Prevents Atherosclerosis Via Inhibiting Lox-1 and Oxidative Stress

Celastrol Causes Apoptosis and Cell Cycle Arrest in Rat Glioma Cells

Celastrol inhibits mouse B16-F10 melanoma cell survival by regulating the PI3K/AKT/mTOR signaling pathway and repressing HIF-1α expression

Celastrol impairs tumor growth by modulating the CIP2A-GSK3β-MCL-1 axis in gastric cancer cells

Celastrol Ameliorates Ulcerative Colitis-Related Colorectal Cancer in Mice via Suppressing Inflammatory Responses and Epithelial-Mesenchymal Transition

Design, synthesis of novel celastrol derivatives and study on their antitumor growth through HIF-1α pathway

Celastrol suppresses growth and induces apoptosis of human hepatocellular carcinoma through the modulation of STAT3/JAK2 signaling cascade in vitro and in vivo.

Celastrol Inhibited Human Esophageal Cancer by Activating DR5-Dependent Extrinsic and Noxa/Bim-Dependent Intrinsic Apoptosis